Recent News
How important is stimulus amid coronavirus vaccine rollout?
Money Map Press chief strategist Shah Gilani, Rosecliff Ventures founder Mike Murphy, and Kingsview Wealth Management CIO Scott Martin discuss stimulus talks and investing in today’s markets.
Dow, S&P slip as de Blasio warns New York City could be shut down
U.S. equity markets trimmed their gains Monday as New York City Mayor Bill de Blasio warned the city could see a full shutdown in the weeks ahead due to a surge in COVID-19 infections and as OPEC cut its oil demand forecast.
$300 billion of M&A to be unleashed by blank-check deals
The mergers and acquisitions boom will continue over the next few years says Goldman Sachs fueled by $61 billion waiting in the wings.
Stock futures pointing higher ahead of opening bell after ending last week on downbeat note
U.S. equity futures are pointing higher early Monday hours before the opening bell after ending last week on a downbeat note. Benchmarks pulled further away from their recent highs Friday as prospects for another aid package from Washington faded, while a surge in virus cases is threatening to inflict more damage on an already battered economy.
CDC's Redfield officially recommends Pfizer coronavirus vaccine
Centers for Disease Control and Prevention Director Dr. Robert Redfield said Sunday that he signed the CDC's official recommendation for Americans 16 and older to use the Pfizer-BioNTech coronavirus vaccine and applauded the vaccine as a step to "help restore some normalcy to our lives and our country."
First shipment of Pfizer-BioNTech coronavirus vaccine leaves Michigan facility
The first truck carrying a COVID-19 vaccine for widespread use in the United States pulled out of a Portage, Mich., manufacturing plant Sunday morning, with the shots that are critical to stopping the nation's coronavirus outbreak destined to reach locations in all 50 states a day later.
AstraZeneca to buy Alexion for $39 billion to expand in immunology
Britain’s AstraZeneca has agreed to buy U.S. drugmaker Alexion Pharmaceuticals for $39 billion in cash and shares to bolster its positions in immunology and rare diseases.
COVID-19 vaccine makers turn to testing children
Health experts urge more research to help curb transmission and to reopen schools.
US Supreme Court takes up Goldman securities class action appeal
Goldman is appealing a decision allowing a class action accusing the bank of hiding conflicts of interest when creating risky subprime securities before the 2008 financial crisis.
How Pfizer delivered a COVID vaccine in record time: Crazy deadlines, a pushy CEO
Albert Bourla and his team overcame unproven science and manufacturing bottlenecks; ‘you’re asking for too much.’